n-3 PUFA and FLAV response to intervention
PC 38:5
As anticipated, OM3FLAV intervention resulted in a significant increase in NEFA EPA and DHA and LPC EPA and DHA, along with PC 38:5, PC 38:6, and PC 40:6 fractions (Plasma n-3 PUFA, and urinary flavonoids at baseline and in response to interventionData are mean (SD); ANCOVA using mixed models for repeated measures, with change from baseline (i.e. 3 mo-0 mo and 12 mo-0 mo) fitted as a fixed repeated factor (2 levels: 3 and 12 mo), and center, age, sex and BMI added as covariates.LPC, lysophosphatidylcholine; PC, phosphatidylcholine, PC.36:5 (16:0/20:5, 16:1/20:4, 18:2/18:3), PC.38:6 (16:0/22:6, 18:1/20:5, 18:2/20:4), PC.40:6 (18:0/22:6, 18:1/22:5, 18:2/22:4, 20:2/20:4); OM3FLAV, omega-3 polyunsaturated fatty acids (EPA+DHA; OM3) + cocoa flavan-3-ols (FLAV).Impact of 3-mo and 12-mo consumption of a DHA-rich fish oil and cocoa flavanol mixture (OM3FLAV; 